Oral administration of heat-killed mycobacterium manresensis delays progression toward active tuberculosis in C3HeB/FeJ mice

Frontiers in Microbiology

Volumn 6, Issue JAN, 2016, Pages

  Cardona, Paula ^a   Marzo Escartín, Elena ^a   Tapia, Gustavo ^a   Díaz, Jorge ^a   García, Vanessa ^a   Varela, Ismael ^a   Vilaplana, Cristina ^a   Cardona, Pere Joan ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

C3HeB FeJ; Mice; Mycobacterium manresensis; Neutrophils; Tolerance; Tregs; Tuberculosis

Indexed keywords

CD39 ANTIGEN; ETHAMBUTOL PLUS ISONIAZID PLUS PYRAZINAMIDE PLUS RIFAMPICIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 5; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CD25+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HEAT KILLED MYCOBACTERIUM MANRESENSIS; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; LUNG INFILTRATE; MOUSE; MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG; NEUTROPHIL CHEMOTAXIS; NONHUMAN; REGULATORY T LYMPHOCYTE; SPLEEN CELL; SURVIVAL; TUBERCULOSIS;

EID: 84957998713     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.01482     Document Type: Article

References (51)

1. Aida, K., Miyakawa, R., Suzuki, K., Narumi, K., Udagawa, T., Yamamoto, Y., et al. (2014). Suppression of Tregs by anti-glucocorticoid induced TNF receptor antibody enhances the antitumor immunity of interferon-a gene therapy for pancreatic cancer. Cancer Sci. 105, 159-167. doi: 10.1111/cas.12332.
2. Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., et al. (2010). An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973-977. doi: 10.1038/nature09247.
3. Bjarnason, I. (2013). Gastrointestinal safety of NSAIDs and over-the-counter analgesics. Int. J. Clin. Pract. Suppl. 178, 37-42. doi: 10.1111/ijcp.12048.
4. Borsellino, G., Kleinewietfeld, M., Di Mitri, D., Sternjak, A., Diamantini, A., Giometto, R., et al. (2007). Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110, 1225-1232. doi: 10.1182/blood-2006-12-064527.
5. Brandt, L., Feino Cunha, J., Weinreich Olsen, A., Chilima, B., Hirsch, P., Appelberg, R., et al. (2002). Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect. Immun. 70, 672-678. doi: 10.1128/IAI.70.2.672-678.2002.
6. Cáceres, N., Tapia, G., Ojanguren, I., Altare, F., Gil, O., Pinto, S., et al. (2009). Evolution of foamy macrophages in the pulmonary granulomas of experimental tuberculosis models. Tuberculosis (Edinb.) 89, 175-182. doi: 10.1016/j.tube.2008.11.001.
7. Cardona, P.-J. (2010). Revisiting the natural history of tuberculosis. The inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active disease. Arch. Immunol. Ther. Exp. (Warsz.) 58, 7-14. doi: 10.1007/s00005-009-0062-5.
8. Cardona, P.-J. (2011). A spotlight on liquefaction: evidence from clinical settings and experimental models in tuberculosis. Clin. Dev. Immunol. 2011:868246. doi: 10.1155/2011/868246.
9. Cardona, P.-J. (2015). The key role of exudative lesions and their encapsulation: lessons learned from the pathology of human pulmonary tuberculosis. Front. Microbiol. 6:612. doi: 10.3389/fmicb.2015.00612.
10. Cardona, P.-J., Gordillo, S., Díaz, J., Tapia, G., Amat, I., Pallarés, A., et al. (2003). Widespread Bronchogenic Dissemination Makes DBA/2 Mice More Susceptible than C57BL/6 Mice to Experimental Aerosol Infection with Mycobacterium tuberculosis. Infect. Immun. 71, 5845-5854. doi: 10.1128/IAI.71.10.5845-5854.2003.
11. Casadevall, A., and Pirofski, L. (2003). The damage-response framework of microbial pathogenesis. Nat. Rev. Microbiol. 1, 17-24. doi: 10.1038/nrmicro732.
12. Chiacchio, T., Casetti, R., Butera, O., Vanini, V., Carrara, S., Girardi, E., et al. (2009). Characterization of regulatory T cells identified as CD4(+)CD25(high)CD39(+) in patients with active tuberculosis. Clin. Exp. Immunol. 156, 463-470. doi: 10.1111/j.1365-2249.2009.03908.x.
13. Collins, F. M. (1971). Immunogenicity of various mycobacteria and the corresponding levels of cross-protection developed between species. Infect. Immun. 4, 688-696.
14. de Cassan, S. C., Pathan, A. A., Sander, C. R., Minassian, A., Rowland, R., Hill, A. V. S., et al. (2010). Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85A. Clin. Vaccine Immunol. 17, 1066-1073. doi: 10.1128/CVI.00047-10.
15. Dunn, P. L., and North, R. J. (1996). Persistent infection with virulent but not avirulent Mycobacterium tuberculosis in the lungs of mice causes progressive pathology. J. Med. Microbiol. 45, 103-109.
16. Dwyer, K. M., Hanidziar, D., Putheti, P., Hill, P. A., Pommey, S., McRae, J. L., et al. (2010). Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. Am. J. Transplant. 10, 2410-2420. doi: 10.1111/j.1600-6143.2010.03291.x.
17. Eruslanov, E. B., Lyadova, I. V., Kondratieva, T. K., Majorov, K. B., Scheglov, I. V., Orlova, M. O., et al. (2005). Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect. Immun. 73, 1744-1753. doi: 10.1128/IAI.73.3.1744-1753.2005.
18. Faria, A. M. C., and Weiner, H. L. (2005). Oral tolerance. Immunol. Rev. 206, 232-259. doi: 10.1111/j.0105-2896.2005.00280.x.
19. Gao, W., Thompson, L., Zhou, Q., Putheti, P., Fahmy, T. M., Strom, T. B., et al. (2009). Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6. Cell Cycle 8, 1444-1450. doi: 10.4161/cc.8.9.8348.
20. Gil, O., Díaz, I., Vilaplana, C., Tapia, G., Díaz, J., Fort, M., et al. (2010). Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs. PLoS ONE 5:e10030. doi: 10.1371/journal.pone.0010030.
21. Green, A. M., Mattila, J. T., Bigbee, C. L., Bongers, K. S., Lin, P. L., and Flynn, J. L. (2010). CD4(+) regulatory T cells in a cynomolgus macaque model of Mycobacterium tuberculosis infection. J. Infect. Dis. 202, 533-541. doi: 10.1086/654896.
22. Gröschel, M. I., Prabowo, S. A., Cardona, P.-J., Stanford, J. L., and van der Werf, T. S. (2014). Therapeutic vaccines for tuberculosis-a systematic review. Vaccine 32, 3162-3168. doi: 10.1016/j.vaccine.2014.03.047.
23. Grosset, J. (2003). Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary. Antimicrob. Agents Chemother. 47, 833-836. doi: 10.1128/AAC.47.3.833-836.2003.
24. Harats, D., Yacov, N., Gilburd, B., Shoenfeld, Y., and George, J. (2002). Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J. Am. Coll. Cardiol. 40, 1333-1338. doi: 10.1016/S0735-1097(02)02135-6.
25. Hawn, T. R., Matheson, A. I., Maley, S. N., and Vandal, O. (2013). Host-directed therapeutics for tuberculosis: can we harness the host? Microbiol. Mol. Biol. Rev. 77, 608-627. doi: 10.1128/MMBR.00032-13.
26. Ho, P., Wei, X., and Seah, G. T. (2010). Regulatory T cells induced by Mycobacterium chelonae sensitization influence murine responses to bacille Calmette-Guerin. J. Leukoc. Biol. 88, 1073-1080. doi: 10.1189/jlb.0809582.
27. Kagina, B. M., Abel, B., Scriba, T. J., Hughes, E. J., Keyser, A., Soares, A., et al. (2010). Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns. Am. J. Respir. Crit. Care Med. 182, 1073-1079. doi: 10.1164/rccm.201003-0334OC.
28. Keller, C., Hoffmann, R., Lang, R., Brandau, S., Hermann, C., and Ehlers, S. (2006). Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes. Infect. Immun. 74, 4295-4309. doi: 10.1128/IAI.00057-06.
29. Leepiyasakulchai, C., Ignatowicz, L., Pawlowski, A., Källenius, G., and Sköld, M. (2012). Failure to recruit anti-inflammatory CD103+ dendritic cells and a diminished CD4+ Foxp3+ regulatory T cell pool in mice that display excessive lung inflammation and increased susceptibility to Mycobacterium tuberculosis. Infect. Immun. 80, 1128-1139. doi: 10.1128/IAI.05552-11.
30. Levy, L., and Ilan, Y. (2007). Oral immune regulation: a new mode of therapy against chronic viral infections. Recent Pat. Antiinfect. Drug Discov. 2, 217-221. doi: 10.2174/157489107782497353.
31. Manca, C., Tsenova, L., Bergtold, A., Freeman, S., Tovey, M., Musser, J. M., et al. (2001). Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc. Natl. Acad. Sci. U.S.A. 98, 5752-5757. doi: 10.1073/pnas.091096998.
32. Marzo, E., Vilaplana, C., Tapia, G., Diaz, J., Garcia, V., and Cardona, P.-J. (2014). Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis. Tuberculosis (Edinb.) 94, 55-64. doi: 10.1016/j.tube.2013.09.004.
33. Michels, S. L., Collins, J., Reynolds, M. W., Abramsky, S., Paredes-Diaz, A., and McCarberg, B. (2012). Over-the-counter ibuprofen and risk of gastrointestinal bleeding complications: a systematic literature review. Curr. Med. Res. Opin. 28, 89-99. doi: 10.1185/03007995.2011.633990.
34. Ochi, H., Abraham, M., Ishikawa, H., Frenkel, D., Yang, K., Basso, A. S., et al. (2006). Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25-LAP+ T cells. Nat. Med. 12, 627-635. doi: 10.1038/nm1408.
35. Orme, I. M., and Collins, F. M. (1984). Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria. Infect. Immun. 44, 28-32.
36. Poyntz, H. C., Stylianou, E., Griffiths, K. L., Marsay, L., Checkley, A. M., and McShane, H. (2014). Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis. Tuberculosis (Edinb.) 94, 226-237. doi: 10.1016/j.tube.2013.12.006.
37. Rech, G., Vilaplana, C., Velasco, J., Pluvinet, R., Santín, S., Prat, C., et al. (2015). Draft genome sequences of mycobacterium setense type strain DSM-45070 and the nonpathogenic strain manresensis, isolated from the Bank of the Cardener River in Manresa, Catalonia, Spain. Genome Announc. 3, e01485-e01514. doi: 10.1128/genomeA.01485-14.
38. Ribeiro-Rodrigues, R., Resende Co, T., Rojas, R., Toossi, Z., Dietze, R., Boom, W. H., et al. (2006). A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis. Clin. Exp. Immunol. 144, 25-34. doi: 10.1111/j.1365-2249.2006.03027.x.
39. Roberts, V., Stagg, J., and Dwyer, K. M. (2014). The Role of Ectonucleotidases CD39 and CD73 and adenosine signaling in solid organ transplantation. Front. Immunol. 5:64. doi: 10.3389/fimmu.2014.00064.
40. Srivastava, S., Koch, M. A., Pepper, M., and Campbell, D. J. (2014). Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection. J. Exp. Med. 211, 961-974. doi: 10.1084/jem.20131556.
41. Tobin, D. M., Vary, J. C., Ray, J. P., Walsh, G. S., Dunstan, S. J., Bang, N. D., et al. (2010). The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140, 717-730. doi: 10.1016/j.cell.2010.02.013.
42. Vilaplana, C., and Cardona, P.-J. (2014). The lack of a big picture in tuberculosis: the clinical point of view, the problems of experimental modeling and immunomodulation. The factors we should consider when designing novel treatment strategies. Front. Microbiol. 5:55. doi: 10.3389/fmicb.2014.00055.
43. Vilaplana, C., Marzo, E., Tapia, G., Diaz, J., Garcia, V., and Cardona, P.-J. (2013). Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis. J. Infect. Dis. 208, 199-202. doi: 10.1093/infdis/jit152.
44. von Reyn, C. F., Mtei, L., Arbeit, R. D., Waddell, R., Cole, B., Mackenzie, T., et al. (2010). Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine. AIDS 24, 675-685. doi: 10.1097/QAD.0b013e3283350f1b.
45. Weiner, H. L., da Cunha, A. P., Quintana, F., and Wu, H. (2011). Oral tolerance. Immunol. Rev. 241, 241-259. doi: 10.1111/j.1600-065X.2011.01017.x.
46. Weir, R. E., Black, G. F., Nazareth, B., Floyd, S., Stenson, S., Stanley, C., et al. (2006). The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guérin vaccination in southern England and northern Malawi. Clin. Exp. Immunol. 146, 390-399. doi: 10.1111/j.1365-2249.2006.03222.x.
47. WHO (2014). Global Tuberculosis Report 2014. Geneva: World Health Organization.
48. Zheng, W., Thorne, N., and McKew, J. C. (2013). Phenotypic screens as a renewed approach for drug discovery. Drug Discov. Today 18, 1067-1073. doi: 10.1016/j.drudis.2013.07.001.
49. Zhou, L., Lopes, J. E., Chong, M. M., Ivanov, I. I., Min, R., Victora, G. D., et al. (2008). TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453, 236-240. doi: 10.1038/nature06878.
50. Zumla, A., Chakaya, J., Hoelscher, M., Ntoumi, F., Rustomjee, R., Vilaplana, C., et al. (2015). Towards host-directed therapies for tuberculosis. Nat. Rev. Drug Discov. 14, 511-512. doi: 10.1038/nrd4696.
51. Zumla, A., and Maeurer, M. (2015). Host-directed therapies for tackling multi-drug resistant tuberculosis: learning from the pasteur-bechamp debates. Clin. Infect. Dis. 61, 1432-1438. doi: 10.1093/cid/civ631.